SCHEMBL917845

SCHEMBL917845

O=S(=O)([O-])CCCCS(=O)(=O)[O-].[Na+].[Na+]

nearest known ligand 0.67

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.67
TSHR P16473 2/20 0.67
GMNN O75496 1/20 0.67
LMNA P02545 1/20 0.67
TP53 P04637 1/20 0.67
MAPK1 P28482 1/20 0.67
THPO P40225 1/20 0.67
HBB P68871 1/20 0.67
PMP22 Q01453 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
KDM4E B2RXH2 1/20 0.56
MAPT P10636 1/20 0.56
ALOX15 P16050 1/20 0.56
BBOX1 O75936 3/20 0.52
ENPEP Q07075 2/20 0.48
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
EPHX2 P34913 1/20 0.37
PABPC1 P11940 1/20 0.33
EIF4H Q15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3385778 0.96 TSHR (0.63) ALDH1A1TSHRGMNNLMNATP53
SCHEMBL3386062 0.96 TSHR (0.63) ALDH1A1TSHRGMNNLMNATP53
SCHEMBL2289785 0.96 TSHR (0.63) ALDH1A1TSHRGMNNLMNATP53
SCHEMBL921255 0.96 TSHR (0.63) ALDH1A1TSHRGMNNLMNATP53
SCHEMBL14974551 0.92 ALDH1A1 (0.58) ALDH1A1TSHRGMNNLMNATP53
Eprodisate SCHEMBL293813 0.92 ALDH1A1 (0.67) ALDH1A1TSHRGMNNLMNATP53
Lithium Ion SCHEMBL28490449 0.92 ALDH1A1 (0.58) ALDH1A1TSHRGMNNLMNATP53
SCHEMBL2288142 0.92 ALDH1A1 (0.58) ALDH1A1TSHRGMNNLMNATP53
Potassium Ion SCHEMBL28472448 0.92 ALDH1A1 (0.58) ALDH1A1TSHRGMNNLMNATP53
Potassium Ion SCHEMBL10537906 0.89 GMNN (0.55) ALDH1A1TSHRGMNNLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116408051-B Sulfonic acid anion hybridization porous material, preparation method and ethylene-ethane separation method 中国石油天然气股份有限公司 2025-01-21 CN claimed
CN-113881725-B Method for preparing 1, 4-butanedisulfonic acid ademetionine salt by electrodialysis 江西兄弟医药有限公司 2024-06-11 CN claimed
CN-116864647-A Lithium battery negative electrode material and preparation method thereof 江西德沅新能源科技有限公司 2023-10-10 CN claimed
CN-116829534-A Preparation method of 1, 4-butanedisulfonic acid 浙江海正药业股份有限公司 2023-09-29 CN claimed
CN-116408051-A Sulfonic acid anion hybridization porous material, preparation method and ethylene-ethane separation method 中国石油天然气股份有限公司 2023-07-11 CN claimed
WO-2023123170-A1 PREPARATION METHOD FOR 1,4-BUTANEDISULFONIC ACID 浙江海正药业股份有限公司 2023-07-06 WO claimed
WO-2023115524-A1 METHOD FOR PREPARING 1,4-BUTANEDISULFONIC ACID SODIUM SALT 浙江海正药业股份有限公司 2023-06-29 WO claimed
CN-113262641-B Anti-pollution reverse osmosis membrane and preparation method and application thereof 蓝星(杭州)膜工业有限公司 2021-12-10 CN claimed
CN-113444757-A Preparation method of 1, 4-butanedisulfonic acid adenosine methionine 贵州卡本嘉泰生物科技产业发展有限公司 2021-09-28 CN claimed
CN-113416156-A Preparation method of 1, 4-butanedisulfonic acid sodium salt 深圳市铭泉盛催化剂有限公司 2021-09-21 CN claimed
CN-113262641-A Anti-pollution reverse osmosis membrane and preparation method and application thereof 蓝星(杭州)膜工业有限公司 2021-08-17 CN claimed
CN-109852157-B High-hardness AR coating liquid and preparation method thereof 东莞南玻太阳能玻璃有限公司 2021-06-18 CN claimed
US-20080027097-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2008-01-31 US claimed
US-7253306-B2 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2007-08-07 US claimed
EP-1646659-A2 IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF Neurochem (International) Limited (CH) 2006-04-19 EP claimed
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2005-06-30 US claimed
WO-2004113391-A2 IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2004-12-29 WO claimed
US-20250388008-A1 FLAME RESISTANT COMPOSITE FABRIC BROOKWOOD COMPANIES INCORPORATED (US) 2025-12-25 US disclosed
EP-0162323-B1 STABLE SULPHO-ADENOSYL-L-METHIONINE (SAME) SALTS, PARTICULARLY SUITABLE FOR PARENTERAL USE BIORESEARCH S.p.A. (IT) 1989-03-08 EP disclosed
EP-0162323-A1 Stable sulpho-adenosyl-l-methionine (same) salts, particularly suitable for parenteral use BIORESEARCH S.p.A. (IT) 1985-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388008-A1 FLAME RESISTANT COMPOSITE FABRIC FAU, PFAS, FLNB ALDH1A1 1163/4885TSHR 69/4885GMNN 1383/4885
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof MPST, TTR, STS ALDH1A1 78/4885TSHR 4762/4885GMNN 1977/4885
US-20080027097-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF MPST, TTR, STS ALDH1A1 78/4885TSHR 4762/4885GMNN 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.